Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

NCT01922258 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators